Pages that link to "Q33991964"
Jump to navigation
Jump to search
The following pages link to Methylation-associated down-regulation of RASSF1A and up-regulation of RASSF1C in pancreatic endocrine tumors (Q33991964):
Displaying 27 items.
- The MST/Hippo Pathway and Cell Death: A Non-Canonical Affair (Q26744308) (← links)
- Surgical and molecular pathology of pancreatic neoplasms (Q26748615) (← links)
- RASSF tumor suppressor gene family: biological functions and regulation (Q26866080) (← links)
- 5-Azacytidine enhances the radiosensitivity of CNE2 and SUNE1 cells in vitro and in vivo possibly by altering DNA methylation (Q27312329) (← links)
- Menin determines K-RAS proliferative outputs in endocrine cells (Q28589291) (← links)
- RASSF1C modulates the expression of a stem cell renewal gene, PIWIL1. (Q34271675) (← links)
- Quantitative analysis of mRNA expression levels and DNA methylation profiles of three neighboring genes: FUS1, NPRL2/G21 and RASSF1A in non-small cell lung cancer patients (Q35794392) (← links)
- RASSF1 tumor suppressor gene in pancreatic ductal adenocarcinoma: correlation of expression, chromosomal status and epigenetic changes (Q35891000) (← links)
- RASSF1 Polymorphisms in Cancer. (Q36020657) (← links)
- Decreased expression of RASSF1A tumor suppressor gene is associated with worse prognosis in clear cell renal cell carcinoma (Q36525418) (← links)
- Epigenetic silencing of RASSF1A deregulates cytoskeleton and promotes malignant behavior of adrenocortical carcinoma. (Q37113671) (← links)
- Epigenetic changes in gastroenteropancreatic neuroendocrine tumours (Q38272919) (← links)
- DNA methylation profiles distinguish different subtypes of gastroenteropancreatic neuroendocrine tumors. (Q38457942) (← links)
- Alternate RASSF1 Transcripts Control SRC Activity, E-Cadherin Contacts, and YAP-Mediated Invasion (Q38821010) (← links)
- NETs: organ-related epigenetic derangements and potential clinical applications (Q38841735) (← links)
- Decreased expression of RASSF1A and up-regulation of RASSF1C is associated with esophageal squamous cell carcinoma (Q39001875) (← links)
- APC alterations are frequently involved in the pathogenesis of acinar cell carcinoma of the pancreas, mainly through gene loss and promoter hypermethylation (Q40174778) (← links)
- Epigenetics of gastroenteropancreatic neuroendocrine tumors: A clinicopathologic perspective (Q42115029) (← links)
- The RASSF1 Gene and the Opposing Effects of the RASSF1A and RASSF1C Isoforms on Cell Proliferation and Apoptosis (Q42857334) (← links)
- The role of TFPI2 hypermethylation in the detection of gastric and colorectal cancer (Q46123774) (← links)
- Aberrant methylation of mutL homolog 1 is associated with increased risk of non-small cell lung cancer. (Q47807283) (← links)
- Molecular Genetics of Gastroenteropancreatic Neuroendocrine Tumours (Q55981792) (← links)
- methylation is a new epigenetic biomarker for colorectal cancer (Q58743445) (← links)
- Genetics and Epigenetics of Gastroenteropancreatic Neuroendocrine Neoplasms (Q64283563) (← links)
- Association of promoter methylation of RASSF1A and KRAS mutations in non-small cell lung carcinoma in Kashmiri population (India) (Q90095282) (← links)
- Methylation Dynamics of RASSF1A and Its Impact on Cancer (Q92027735) (← links)
- Protein expression of KIT, BRAF, GNA11, GNAQ and RASSF1 in feline diffuse iris melanomas (Q93021928) (← links)